FAKTOR-VIII-POLYPEPTIDFORMULIERUNGEN

Patent europeic · EP3666283 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3666283
Numer da la dumonda
EP19212900
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
14-03-2014
Publitgà
17-06-2020
Concedì
08-06-2022
La protecziun finescha il pli tard
13-03-2034
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
A61K 38/37 (2006.01)
A61P 7/00 (2006.01)
A61P 7/04 (2006.01)
A61P 43/00 (2006.01)
Prioritad
US 201361800293 P 15.03.2013
US 201361817085 P 29.04.2013
US 201361829884 P 31.05.2013
US 201361839477 P 26.06.2013
US 201361863860 P 08.08.2013
US 201361876927 P 12.09.2013
US 201361879955 P 19.09.2013
US 201361897742 P 30.10.2013
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Midada

    Published in Swissreg on 01.04.2026

  2. 01-04-2025

    Midada

    Published in Swissreg on 01.04.2025

  3. 01-04-2024

    Midada

    Published in Swissreg on 01.04.2024

  4. 19-04-2023

    Midada

    Published in Swissreg on 19.04.2023

  5. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  6. 08-06-2022

    Concedì

    Published in Swissreg on 08.06.2022

Partidas

Possessur

Bioverativ Therapeutics Inc.

225 Second Avenue, Waltham MA 02451, US

Inventur

ABDUL-FATTAH, Ahmad

Cambridge, MA Massachusetts 02142, US

GAGE, Daniel

Cambridge, MA Massachusetts 02142, US

MALONEY, Kevin

Cambridge, MA Massachusetts 02142, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.